Champions Oncology, Inc. Q2 FY2021 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2021 Q2 Call date: 2020-12-14 Concluded

Quarter scorecard

Revenue

$10.12M

+32.7% YoY

Diluted EPS

$0.00

-100% YoY

Net income

$1,000

-99.7% YoY

Pharmacology Services $10.04M

+36.5%

Product And Service Other $39,000

+11.4%

Personalized Oncology Services $37,000

-84.1%